STOCK TITAN

Synergy CHC to be delisted from Nasdaq Sept. 18

Synergy CHC Corp. (SNYR) reports that Nasdaq has moved to delist its common stock following the company’s recent Chapter 11 filing.

(High)
(Negative)
Form Type
8-K

Rhea-AI Filing Summary

Synergy CHC Corp. (SNYR) reports that Nasdaq has moved to delist its common stock following the company’s recent Chapter 11 filing. The company received a Delisting Notice on September 11, 2026, stating that trading on Nasdaq will be suspended at the opening of business on September 18, 2026.

Nasdaq’s decision cites the Chapter 11 bankruptcy cases, public interest concerns, questions about residual equity value for current holders, and the company’s ability to sustain compliance with Nasdaq listing standards. Synergy CHC Corp. does not intend to appeal, and a Form 25-NSE is expected to remove its securities from Nasdaq listing.

Positive

  • None.

Negative

  • Nasdaq delisting and trading suspension: Nasdaq staff determined to delist Synergy CHC Corp.’s common stock, with trading on Nasdaq to be suspended at the opening of business on September 18, 2026, following the company’s Chapter 11 bankruptcy filing and related compliance concerns.

Insights

Analyzing...

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Delisting Notice date September 11, 2026 Date Nasdaq staff notified Synergy CHC Corp. of its decision to delist the securities
Trading suspension date September 18, 2026 Date when trading of common stock on Nasdaq is expected to be suspended at the opening of business
Chapter 11 filing date September 4, 2026 Date Synergy CHC Corp. and certain subsidiaries filed voluntary Chapter 11 petitions
Trading symbol SNYR Symbol for Synergy CHC Corp.’s common stock listed on Nasdaq
Delisting Notice regulatory
"the Company received a letter (the “Delisting Notice”) from the staff of the Nasdaq"
Form 25-NSE regulatory
"a Form 25-NSE will be filed with the Securities and Exchange Commission"
Form 25‑NSE is an official filing used to notify the stock exchange that a company’s securities are being removed from trading on that exchange, similar to handing in a key when a shop closes. Investors care because removal ends public trading on that venue, often cutting liquidity and making it harder to buy or sell shares, which can affect a stock’s price and how quickly investors can access cash or exit positions.
chapter 11 regulatory
"filed voluntary petitions for relief under chapter 11 of Title 11"
Chapter 11 is a U.S. bankruptcy process that lets a financially distressed company keep operating while it reorganizes its debts and business plan under court supervision. Think of it as a formal pause that allows the company to renegotiate payments, shed contracts or assets, and seek a path to profitability instead of being liquidated; investors watch it because it can change the value and priority of claims, equity dilution, or the likelihood of recovery.
Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1 regulatory
"will be delisted from Nasdaq pursuant to Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Synergy CHC Corp. (SNYR) announce about its Nasdaq listing?

Synergy CHC Corp. announced that Nasdaq staff issued a Delisting Notice on September 11, 2026, determining that the company’s securities will be delisted. Trading on Nasdaq is expected to be suspended at the opening of business on September 18, 2026.

Why is Synergy CHC Corp. (SNYR) being delisted from Nasdaq?

Nasdaq cited Synergy CHC Corp.’s Chapter 11 bankruptcy filing, associated public interest concerns, concerns about residual equity interest for existing holders, and concerns about the company’s ability to sustain compliance with all Nasdaq listing requirements.

When will trading of SNYR common stock be suspended on Nasdaq?

Trading of Synergy CHC Corp.’s common stock on Nasdaq is expected to be suspended at the opening of business on September 18, 2026, according to the Delisting Notice from Nasdaq staff.

Is Synergy CHC Corp. appealing Nasdaq’s delisting determination?

No. Synergy CHC Corp. does not presently intend to appeal Nasdaq staff’s delisting determination, and therefore expects its common stock trading on Nasdaq to be suspended on September 18, 2026.

What regulatory filing will remove SNYR from Nasdaq listing?

Nasdaq staff indicated that a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove Synergy CHC Corp.’s securities from listing on Nasdaq following the trading suspension.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001562733 0001562733 2026-09-11 2026-09-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 11, 2026

 

SYNERGY CHC CORP.

(Exact name of registrant as specified in its charter)

 

Nevada   001-42374   99-0379440
(State or Other Jurisdiction   (Commission File Number)   (IRS Employer
of Incorporation)       Identification No.)

 

770 Roosevelt Trail STE 8 #1016, N. Windham, Maine   04062
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (207) 321-2350

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.00001 per share   SNYR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR § 240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

As previously reported, Synergy CHC Corp. (the “Company”) and certain of its subsidiaries filed voluntary petitions for relief under chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Columbia, on September 4, 2026 (the “Bankruptcy Filing”).

 

On September 11, 2026, the Company received a letter (the “Delisting Notice”) from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff had determined that the Company’s securities will be delisted from Nasdaq pursuant to Nasdaq Listing Rules 5101, 5110(b) and IM-5101-1. Pursuant to the Delisting Notice, Nasdaq’s determination was based on the following factors: (i) the Bankruptcy Filing and associated public interest concerns raised by it, (ii) concerns regarding the residual equity interest of the existing listed securities holders, and (iii) concerns about the Company’s ability to sustain compliance with all requirements for continued listing on Nasdaq.

 

The Delisting Notice indicates that the trading of the Company’s common stock on Nasdaq will be suspended at the opening of business on September 18, 2026, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company’s securities from listing on Nasdaq.

 

The Company does not presently intend to appeal the Staff’s determination. Therefore, the Company expects that the trading of the Company’s common stock on Nasdaq will be suspended at the opening of business on September 18, 2026.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 16, 2026    
     
  SYNERGY CHC CORP.
     
  By: /s/ Jack Ross
  Name:  Jack Ross
  Title: Authorized Signatory

 

2

 

Filing Exhibits & Attachments

3 documents

Keep reading